You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiolabeled

Showing 1 - 25 of 689
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteer, Muscular Dystrophies, Muscular Disorders, Atrophic Trial in Madison (EDG-5506 Tablet, Radiolabeled EDG-5506

Recruiting
  • Healthy Volunteer
  • +7 more
  • EDG-5506 Tablet
  • +2 more
  • Madison, Wisconsin
    Labcorp Clinical Research Unit, Inc.
Feb 7, 2023

Ovarian Cancer Trial in New York (90Y-hu3S193, 111In-hu3S193)

Completed
Has Results
  • Ovarian Cancer
  • 90Y-hu3S193
  • 111In-hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Healthy Subjects Trial in Nottingham (Quizartinib diHCl, 14C-Quizartinib solution for infusion)

Completed
Has Results
  • Healthy Subjects
  • Quizartinib dihydrochloride
  • 14C-Quizartinib solution for infusion
  • Nottingham, United Kingdom
    Quotient Sciences
Apr 15, 2022

HIV Trial in London (GSK3640254 Oral tablet, [14C]-GSK3640254 intravenous infusion, [14C]-GSK3640254 powder)

Completed
Has Results
  • HIV Infections
  • GSK3640254 Oral tablet
  • +2 more
  • London, United Kingdom
    GSK Investigational Site
Nov 19, 2021

Healthy Trial in Lincoln ([14C]-ALXN2050)

Completed
  • Healthy
  • Lincoln, Nebraska
    Clinical Trial Site
Jan 23, 2023

RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter

Active, not recruiting
  • Infective Endocarditis
  • 18F-FDG PET/CT
  • Quebec, Canada
    Centre de recherche de L'Institut universitaire de cardiologie e
Feb 10, 2022

Acute Myeloid Leukemia Trial in Houston (SNDX-5613)

Recruiting
  • Acute Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Oct 3, 2022

Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))

Completed
  • Liver Cancer
  • Hepatoma
  • Yttrium 90 (TheraSphere)
  • (no location specified)
Sep 28, 2022

Neuroendocrine Tumors Trial in New York (PET/CT Imaging, 68Ga-DOTA-JR11, 177Lu-DOTA-JR11)

Completed
Has Results
  • Neuroendocrine Tumors
  • PET/CT Imaging
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2022

Non-Hodgkin's Lymphoma, Lymphoma, B-Cell Trial (radiolabeled epratuzumab)

Completed
  • Non-Hodgkin's Lymphoma
  • Lymphoma, B-Cell
  • radiolabeled epratuzumab
  • (no location specified)
Aug 12, 2021

Systemic Amyloidosis Trial in Knoxville (Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01))

Active, not recruiting
  • Systemic Amyloidosis
  • Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 28, 2023

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 19, 2023

Healthy Trial in Cincinnati, Seattle (INTERCEPT Treated Platelets)

Completed
  • Healthy
  • INTERCEPT Treated Platelets
  • Cincinnati, Ohio
  • +1 more
Aug 30, 2021

Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

Completed
Has Results
  • Kidney Cancer
  • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Healthy Trial in Madison (Radiolabeled SPD602 (FBS0701, SSP-004184))

Completed
Has Results
  • Healthy
  • Radiolabeled SPD602 (FBS0701, SSP-004184)
  • Madison, Wisconsin
    Covance Clinical Research Unit Inc
Jun 22, 2021

Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

Recruiting
  • Refractory Thyroid Gland Carcinoma
  • +3 more
  • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
  • +2 more
  • Xiamen, China
    The First Affiliated Hospital of Xiamen University
Nov 3, 2022

Prostate Cancer Trial in United States (177Lu-J591, Ketoconazole, Hydrocortisone)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
  • +8 more
Mar 25, 2022

Coronary Artery Disease Trial in Aarhus N ([O-15]-Water PET Myocardial Perfusion Imaging (MPI))

Recruiting
  • Coronary Artery Disease
  • [O-15]-Water PET Myocardial Perfusion Imaging (MPI)
  • Aarhus N, Denmark
    Aarhus University Hospital
Jun 10, 2022

Healthy Volunteers Trial in Madison (Radiolabeled SPD557)

Completed
Has Results
  • Healthy Volunteers
  • Radiolabeled SPD557
  • Madison, Wisconsin
    Covance
May 26, 2021

Healthy Trial in Madison (Radiolabeled Prucalopride Succinate)

Completed
Has Results
  • Healthy
  • Radiolabeled Prucalopride Succinate
  • Madison, Wisconsin
    Covance Global Clinical Research Unit Inc.
May 26, 2021

Healthy Volunteers Trial in Boston, New York (BIIB067, 99mTc-MAG3-BIIB067)

Completed
  • Healthy Volunteers
  • Boston, Massachusetts
  • +1 more
Jul 16, 2021

Withdrawal Symptoms, Opioid Use Disorder, Opioid Use Trial in Atlanta (Transcutaneous Cervical Vagal Nerve Stimulation, Sham

Not yet recruiting
  • Withdrawal Symptoms
  • +2 more
  • Transcutaneous Cervical Vagal Nerve Stimulation
  • +2 more
  • Atlanta, Georgia
  • +6 more
Apr 14, 2023

Ovarian Cancer Trial in Indianapolis, Saint Louis, Houston (radionuclide imaging, indium In 111 folic acid)

Completed
  • Ovarian Cancer
  • radionuclide imaging
  • indium In 111 folic acid
  • Indianapolis, Indiana
  • +2 more
Sep 24, 2021

Endocarditis, Thrombosis Trial in Paris (99mTc-Annexin V-128 SPECT)

Terminated
  • Endocarditis
  • Thrombosis
  • 99mTc-Annexin V-128 SPECT
  • Paris, France
    Bichat Hospital
Aug 25, 2021